计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| F649416-1mg |
1mg |
期货 ![]() |
| |
| F649416-5mg |
5mg |
期货 ![]() |
| |
| F649416-10mg |
10mg |
期货 ![]() |
| |
| F649416-50mg |
50mg |
期货 ![]() |
| |
| F649416-100mg |
100mg |
期货 ![]() |
| |
| F649416-250mg |
250mg |
期货 ![]() |
|
| 规格或纯度 | ≥98% |
|---|---|
| 英文名称 | FIDAS-5 |
| 生化机理 | FIDAS-5 是一种强效的蛋氨酸 S-腺苷转移酶 2A(MAT2A)口服活性抑制剂,IC50 为 2.1 μM。FIDAS-5 能有效竞争 S-腺苷蛋氨酸(SAM)与 MAT2A 的结合。FIDAS-5 具有抗癌活性。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
FIDAS-5 is a potent and orally active methionine S-adenosyltransferase 2A (MAT2A) inhibitor with an IC 50 of 2.1 μM. FIDAS-5 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-5 has anticancer activities In Vitro FIDAS-5 (3 μM; 7 days; LS174T cells) treatment significantly inhibits the proliferation of LS174T cells. ?\nFIDAS-5 (3 μM) treatment inhibits the expression of c-Myc and cyclinD1 in LS174T CRC cells. And FIDAS-5 induces the expression of cell cycle inhibitor, p21 WAF1/CIP1. ?\nFIDAS-5 (3 μM; 36 h) treatment reduces the levels of both S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in LS174T cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: LS174T colorectal cancer (CRC) cells Concentration: 3 μM Incubation Time: 7 days Result: Significantly inhibited the proliferation of LS174T cells. In Vivo FIDAS-5 (20 mg/kg; oral gavage; daily; for two weeks; athymic nude mice) treatment significantly inhibits the growth of xenograft tumors, with minimal difference in body weight . ?\nMice are treated with FIDAS-5 (20 mg/kg) for 1 week. The liver SAM levels are significantly reduced . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: 16 athymic nude mice injected with HT29 CRC cells Dosage: 20 mg/kg Administration: Oral gavage; daily; for two weeks Result: Significantly inhibited the growth of xenograft tumors. Form:Solid IC50& Target:IC50: 2.1 μM (Methionine S-adenosyltransferase 2A (MAT2A)) |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 4-[(E)-2-(2-chloro-6-fluorophenyl)ethenyl]-N-methylaniline |
| INCHI | 1S/C15H13ClFN/c1-18-12-8-5-11(6-9-12)7-10-13-14(16)3-2-4-15(13)17/h2-10,18H,1H3/b10-7+ |
| InChi Key | KXVXICBOMOGFMH-JXMROGBWSA-N |
| Smiles | CNC1=CC=C(C=C1)C=CC2=C(C=CC=C2Cl)F |
| Isomeric SMILES | CNC1=CC=C(C=C1)/C=C/C2=C(C=CC=C2Cl)F |
| PubChem CID | 57521314 |
| 分子量 | 261.72 |
| 溶解性 | DMSO : 125 mg/mL (477.61 mM; Need ultrasonic) |
|---|---|
| 分子量 | 261.720 g/mol |
| XLogP3 | 4.900 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 2 |
| 可旋转键计数Rotatable Bond Count | 3 |
| 精确质量Exact Mass | 261.072 Da |
| 单同位素质量Monoisotopic Mass | 261.072 Da |
| 拓扑极表面积Topological Polar Surface Area | 12.000 Ų |
| 重原子数Heavy Atom Count | 18 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 274.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 1 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 1 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |